Home

Mýdlo Chci Parametry rocaglamide a Trapné vnitrozemí Řečník

PDF] Reanalysis of ribosome profiling datasets reveals a function of rocaglamide  A in perturbing the dynamics of translation elongation via eIF4A by Fajin  Li, Jianhuo Fang, Yifan Yu, Sijia Hao, Qin Zou,
PDF] Reanalysis of ribosome profiling datasets reveals a function of rocaglamide A in perturbing the dynamics of translation elongation via eIF4A by Fajin Li, Jianhuo Fang, Yifan Yu, Sijia Hao, Qin Zou,

Rocaglamide-A directly promoted osteoblast differentiation in C2C12... |  Download Scientific Diagram
Rocaglamide-A directly promoted osteoblast differentiation in C2C12... | Download Scientific Diagram

Reanalysis of ribosome profiling datasets reveals a function of rocaglamide  A in perturbing the dynamics of translation elongation via eIF4A | Nature  Communications
Reanalysis of ribosome profiling datasets reveals a function of rocaglamide A in perturbing the dynamics of translation elongation via eIF4A | Nature Communications

Cancers | Free Full-Text | Identification of Cardiac Glycosides as Novel  Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer  Cells
Cancers | Free Full-Text | Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells

Rocaglamide (Roc-A) | NF-κB Inhibitor | MedChemExpress
Rocaglamide (Roc-A) | NF-κB Inhibitor | MedChemExpress

Rocaglamide - an overview | ScienceDirect Topics
Rocaglamide - an overview | ScienceDirect Topics

The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between  eIF4A and Polypurine RNA
The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA

Molecular mechanisms and anti‐cancer aspects of the medicinal  phytochemicals rocaglamides (=flavaglines) - Li‐Weber - 2015 -  International Journal of Cancer - Wiley Online Library
Molecular mechanisms and anti‐cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines) - Li‐Weber - 2015 - International Journal of Cancer - Wiley Online Library

ROCAGLAMIDE | 84573-16-0
ROCAGLAMIDE | 84573-16-0

Total Synthesis of (±)-Rocaglamide via Oxidation-Initiated Nazarov  Cyclization | The Journal of Organic Chemistry
Total Synthesis of (±)-Rocaglamide via Oxidation-Initiated Nazarov Cyclization | The Journal of Organic Chemistry

Rocaglamide A - List of Frontiers' open access articles
Rocaglamide A - List of Frontiers' open access articles

Rocaglamide, silvestrol and structurally related bioactive compounds from  Aglaia species - Natural Product Reports (RSC Publishing)
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species - Natural Product Reports (RSC Publishing)

Rocaglamide A - List of Frontiers' open access articles
Rocaglamide A - List of Frontiers' open access articles

Progress in the Total Synthesis of Rocaglamide
Progress in the Total Synthesis of Rocaglamide

Rocaglamide - Wikipedia
Rocaglamide - Wikipedia

Evidence for a Functionally Relevant Rocaglamide Binding Site on the  eIF4A–RNA Complex | ACS Chemical Biology
Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex | ACS Chemical Biology

Rocaglamide (NSC 326408, Roc-A, Rocaglamide A, CAS Number: 84573-16-0) |  Cayman Chemical
Rocaglamide (NSC 326408, Roc-A, Rocaglamide A, CAS Number: 84573-16-0) | Cayman Chemical

Rocaglamide (Roc-A) | NF-κB Inhibitor | MedChemExpress
Rocaglamide (Roc-A) | NF-κB Inhibitor | MedChemExpress

Rocaglamide overcomes tumor necrosis factor‑related apoptosis‑inducing  ligand resistance in hepatocellular carcinoma cells by attenuating the  inhibition of caspase‑8 through cellular FLICE‑like‑inhibitory protein  downregulation
Rocaglamide overcomes tumor necrosis factor‑related apoptosis‑inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase‑8 through cellular FLICE‑like‑inhibitory protein downregulation

Natural plant defense could lead to new personalized cancer therapy | RIKEN
Natural plant defense could lead to new personalized cancer therapy | RIKEN

Rocaglamide | CAS:84573-16-0 | Alkaloids | High Purity | Manufacturer  BioCrick
Rocaglamide | CAS:84573-16-0 | Alkaloids | High Purity | Manufacturer BioCrick

Rocaglamide | C29H31NO7 | CID 331783 - PubChem
Rocaglamide | C29H31NO7 | CID 331783 - PubChem

Molecular mechanisms and anti‐cancer aspects of the medicinal  phytochemicals rocaglamides (=flavaglines) - Li‐Weber - 2015 -  International Journal of Cancer - Wiley Online Library
Molecular mechanisms and anti‐cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines) - Li‐Weber - 2015 - International Journal of Cancer - Wiley Online Library

Evidence for a Functionally Relevant Rocaglamide Binding Site on the  eIF4A–RNA Complex | ACS Chemical Biology
Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex | ACS Chemical Biology

Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in  T-cells - ScienceDirect
Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in T-cells - ScienceDirect

Rocaglamide | CAS# 84573-16-0 | 1863 | BioVision, Inc.
Rocaglamide | CAS# 84573-16-0 | 1863 | BioVision, Inc.

Chemical structure of rocaglamide and silvestrol. (b) Primary AML cells...  | Download Scientific Diagram
Chemical structure of rocaglamide and silvestrol. (b) Primary AML cells... | Download Scientific Diagram

Rocaglamide, a natural anti-cancer by Inès Hugonneau Beaufet
Rocaglamide, a natural anti-cancer by Inès Hugonneau Beaufet